Wedbush Downgrades iTeos Therapeutics (ITOS) to Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Wedbush Downgrades iTeos Therapeutics (ITOS) to Neutral

iTeos Therapeutics Announces Its Intention to Wind Down Operations

May 28, 2025 8:30 AM EDT

- Board of Directors intends to cease operations

- Company to focus efforts on selecting best path to deliver near-term value to shareholders

- Exploring potential asset sales including EOS-984, EOS-215, and a preclinical obesity program targeting ENT1

WATERTOWN, Mass. and GOSSELIES, Belgium, May 28, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today announced the intention to wind down its operations... More